de completadas
de completadas
Laboratory value | Results | |
4 weeks ago | Today | |
Serum chemistry | ||
Sodium | 138 mEq/L | 137 mEq/L |
Potassium | 4 mEq/L | 4.1 mEq/L |
Bicarbonate | 24 mEq/L | 25 mEq/L |
Chloride | 96 mEq/L | 94 mEq/L |
Creatinine | 1.1 mg/dL | 1.6 mg/dL |
Urinalysis | ||
Protein | 100 mg/day | 102 mg/day |
Cast | None | None |
Blood | negative | negative |
2024
2023
2022
2021
renal papillary necrosis and p. 619
renal papillary necrosis and p. 619
renal papillary necrosis p. 621-NaN
renal papillary necrosis p. 620
renal papillary necrosis and p. 620
pyelonephritis and p. 619
sickle cell anemia p. 415
renal papillary necrosis p. 621
Renal papillary necrosis is a condition in which impaired blood supply to the kidneys leads to diffuse ischemia and subsequent necrosis of the renal papilla. Risk factors for renal papillary necrosis include diabetes, sickle cell anemia, and certain medications such as non-steroidal anti-inflammatory drugs (NSAIDs). Symptoms may include fever, flank pain, and blood in the urine. Treatment may include antibiotics, pain management, and in severe cases, surgery.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.